Global E. Coli Testing Market: Snapshot
E. coli (Escherichia coli) is a fecal coliform bacteria commonly found in intestines of humans and animals. Most of the E. coli strains are harmless, however certain strains are known to cause harmful medical complications. These include neonatal meningitis, gastrointestinal infections, cholecystitis, bacteremia, urinary tract infection (UTI), cholangitis, and pneumonia and mainly spreads through contaminated water or food. As this organism is found in intestinal tract of humans, it is considered as an indicator of fecal contamination. Hence, food and water samples are regularly tested for E. coli to avoid foodborne infections.
Sudden outbreak of drug resistant E. coli strains has raised serious health concerns. The epidemic has spread to various regions of the world including North America and parts of Europe. These factors have led governments and regulatory agencies to adopt preventive measures to avoid such epidemics. Hence Environment Protection Agencies (EPA) across the globe have laid strict guidelines for water testing. These guidelines are practiced by municipal water suppliers, bottled water suppliers, waste water treatment plants, and private well owners.
Spurred by these factors, the global E. coli testing market is expected to reach US$2.36 bn by the end of 2025, from US$1.18 bn in 2016. If these figures hold true, the global E. coli testing market will exhibit a CAGR of 8.0% between 2017 and 2025.
Home and Drinking Water Segment to Continue Exhibiting Highest Demand
In terms of environmental testing methods, the global E. coli testing market is bifurcated into environmental testing method and clinical testing methods. The environmental testing method segment is further classified into membrane filtration (MF), multiple tube fermentation (MTF), and enzyme substrate method. Of these, holding majority share, the enzyme substrate method emerged dominant in the market in 2016. As the method is relatively more cost-effective and does not require skilled professionals for conducting it, is likely to retain its top slot through the forecast period.
Likewise, the clinical testing segment is classified into polymerase chain reaction (PCR), enzyme immunoassay (EIA) tests, and others. Of these, enzyme immunoassays testing will continue holding the largest share in the market through the forecast period.
By end user, the market can be categorized as waste water treatment organizations, bottled water suppliers, home and drinking water suppliers, and others. Of these, holding over 49.7% of the market, the home and drinking water segment emerged dominant in 2016. While the segment is expected to remain at the lead through the coming years, the market will also witness rising demand from waste water treatment organizations. Furthermore, the increasing drinking water crisis and frequent outbreak of water borne diseases will put pressure on governments to ensure high standards of home and drinking water, thus sealing the dominance of the segment.
North America to Remain Dominant Regional Market through Forecast Period
Regionally, the global E. coli testing market has been segmented into five major regions: North America, Europe, Asia Pacific, Latin America and Middle East & Africa. In 2016, North America held the dominant share of nearly 44.5% in the global E. coli testing market. North America has been one of the early adopters of the latest technologies. Besides this, the region also boasts a sophisticated healthcare infrastructure, which is aiding the growth of the E. coli testing market.
Meanwhile, the Europe market is saturated and growing at slow rate while Asia Pacific is anticipated to witness the fastest CAGR during the forecast period with major contribution of countries such as India, Japan and China. New product launches, favorable regulations, ability of patients to pay for advanced technology products, and growing awareness are likely to drive the market in Asia Pacific during the forecast period.
Some of the key players operating in the E. coli testing market are IDEXX Laboratories, Inc., Meridian Bioscience, Inc., Becton, Dickinson and Company, Thermo Fisher Scientific, Inc., CPI International, Inc., Bio-Rad Laboratories, Inc., Pro-Lab Diagnostics, Inc., Alere Inc., BioMerieux Inc., and NanoLogix, Inc.
Global E. Coli Testing Market: Overview
This report on E. coli testing market studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries engaged in the manufacture, commercialization, providing services of E. coli testing products such as membrane filtration (MF), multiple tube fermentation (MTF), enzyme substrate methods, polymerase chain reaction (PCR) tests, and enzyme immunoassays (EIA) as well as new entrants planning to enter this market. This report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments and sub-segments considered in the scope of the study. This section also provides the overall information and data analysis of the global market with respect to the leading market segments based on major testing methods segment, end-user, and geographies.
Global E. Coli Testing Market: Scope of the Report
The market overview section of the report explores the market dynamics such as drivers, restraints, and opportunities that currently have a strong impact on the E. coli testing market and could influence the market in the near future. Market attractiveness analysis has been provided in the market overview section in order to explain the intensity of competition in the market across different geographies. The competitive scenario among different market players is evaluated through market share analysis in the competitive landscape section of the report. All these factors would help market players to take strategic decisions in order to strengthen their positions and expand their shares in the global market.
Global E. Coli Testing Market: Key Segments
Based on testing methods, the E. coli testing market has been majorly segmented into: environmental testing method and clinical testing method. In terms of environmental testing methods divided into membrane filtration (MF), multiple tube fermentation (MTF), and enzyme substrate methods. In terms of clinical testing methods divided into polymerase chain reaction (PCR) tests, enzyme immunoassays (EIA) and others. Based on end-users, the market has been broadly classified into environmental testing end-user and clinical testing end-user. Each of the market segments have been extensively analyzed based on the market related factors such as increasing rate of E. coli related disease incidences and adoption of E. coli tests for water testing worldwide, technological advancement, and growing number of use of water testing E. coli test in various geographies.
Moreover, historical year-on-year growth have been taken into consideration while estimating the market size. The market size and forecast in terms of US$ million for each segment has been provided for the period from 2015 to 2025. The report also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2017 to 2025, considering 2016 as the base year.
Global E. Coli Testing Market: Regional Outlook
Geographically, the market has been segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market size and forecast for each of these regions has been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year. The report also provides with market size and forecast for major countries in the respective regions. A detailed qualitative analysis of factors responsible for driving and restraining the market growth and future opportunities has been provided in the market overview section. This section of the report also provides with market attractiveness analysis, porter’s five forces analysis, and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the global E. coli testing market.
Companies Mentioned in the Report
The key findings section included in the report would assist existing market players in expanding their market shares, and new companies in establishing their presence in the global E. coli testing market. The report also profiles key players operating in the market which are IDEXX Laboratories, Inc., Meridian Bioscience, Inc., Becton, Dickinson and Company, Thermo Fisher Scientific, Inc., CPI International, Inc., Bio-Rad Laboratories, Inc., Pro-Lab Diagnostics, Inc., Alere Inc., BioMerieux Inc., NanoLogix, Inc. and other prominent companies.
The global E. coli testing market is segmented as follows:
Global E. Coli Testing Market, by Testing Methods
- Environmental Testing Method
- Membrane Filtration (MF)
- Multiple Tube Fermentation (MTF)
- Enzyme Substrate Methods
- Clinical Testing Method
- Polymerase Chain Reaction (PCR) Tests
- Enzyme Immunoassays (EIA)
- Others
Global E. Coli Testing Market, by End-user
- Environmental Testing Method
- Home and Drinking Water Suppliers
- Bottled Water Suppliers
- Waste Water Treatment Organizations
- Others (Government Agencies, Private Well Owners, Ground Water Testing and Farm Water Testing)
- Clinical Testing Method
- Hospital
- Diagnostic Laboratories
- Physician Offices
Global E. Coli Testing Market, by Geography
- North America
- U.S.
- Canada
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Rest of the Europe
- Asia Pacific
- China
- Japan
- Australia & New Zealand
- Rest of Asia
- Latin America (LATAM)
- Brazil
- Mexico
- Rest of LATAM
- Middle East & Africa
- GCC Countries
- South Africa
- Rest of Middle East & Africa
